Evidence map›Paper›PMID 19336234›Full record

ArticleFEBS letters2009

Identification of LTR-specific small non-coding RNA in FeLV infected cells.

Lora W Forman, Ruma Pal-Ghosh, Remco A Spanjaard, Douglas V Faller, Sajal K Ghosh

Abstract read
In one paragraph

Article in FEBS letters, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Prevalence of feline leukaemia provirus DNA in feline lymphomas.Journal of feline medicine and surgery · 2010
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lora W FormanCancer Research Center, Department of Medicine, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02458, USA.
Ruma Pal-Ghosh
Remco A Spanjaard
Douglas V Faller
Sajal K Ghosh

Funding

Ras Oncoprotein-Targeted Therapy for CancerR01CA112102 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FALLER, DOUGLAS V · 2005 to 2009
$1.7M
NCI NIH HHS CA112102NCI NIH HHS R01 CA112102
6 · The paper itself

Abstract

The U3-LTR region of leukemia viruses transactivates cancer-related signaling pathways through the production of a non-coding RNA transcript although the role of this transcript in virus infection remains unknown. In this study we demonstrate for the first time that an long terminal repeat (LTR)-specific small non-coding RNA is produced from a feline leukemia virus (FeLV)-infected feline cell line. RNA cloning identified this as a 104 base transcript that originates from the U3-LTR region. We also demonstrate that in in vitro assays this LTR-RNA transcript activates NF kappaB signaling. Taken together, our findings suggest a possible role for this LTR transcript in FeLV pathogenesis.

Indexed as

Repetitive Sequences, Nucleic AcidRNA, UntranslatedAnimalsBase SequenceBlotting, NorthernCatsCell LineDNA PrimersLeukemia Virus, FelineTranscriptional ActivationDNA PrimersRNA, Untranslated

Identifiers

PMID19336234
PMCPMC3774839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.